Press releases & Media
Press releases
-
A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA
September 13, 2023
-
Stockholm3 combines accurate diagnosis of prostate cancer with improved health economics
August 31, 2023
-
Stockholm3 included in the American Urological Association (AUA) guidelines for early detection of prostate cancer
May 4, 2023
A3P in media
-
Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
May 6, 2022
-
Finally time for public screening of prostate cancer? (In Swedish)
November 22, 2021
-
Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
October 6, 2021